Federal Register, Volume 74, Number 84, May 4, 2009, Pages 20405-20558 Page: 20,487
vii, 20557, ii p. ; 28 cm.View a full description of this periodical.
Extracted Text
The following text was automatically extracted from the image on this page using optical character recognition software:
Federal Register/Vol. 74, No. 84/Monday, May 4, 2009 / Notices
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency's estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Dated: April 29, 2009.
Janean Chambers,
Reports Clearance Officer.
[FR Doc. E9-10133 Filed 5-1-09; 8:45 am]
BILLING CODE 4184-01-P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Organ
Transplant Infection Detection and
Prevention Program, Funding
Opportunity Announcement (FOA)
CK09-003, Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92-463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 12 p.m.-3 p.m., June 11,
2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of "Organ Transplant Infection
Detection and Prevention Program, FOA
CK09-003."
Contact Person for More Information:
Wendy Carr, PhD, CDC, 1600 Clifton Road,
NE., Mailstop D60, Atlanta, GA 30333,
Telephone: (404) 498-2276.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for ToxicSubstances and Disease Registry.
Dated: April 24, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9-10193 Filed 5-1-09; 8:45 am]
BILLING CODE 4163-18-P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Evaluation of
New Technology To Improve Delivery
of Immunizations, Funding
Opportunity Announcement (FOA)
IP09-005 Initial Review; Development,
Implementation and Evaluation of
Strategies To Increase Vaccination of
Adolescents Affiliated With a Medical
Home, FOA IP09-006 Initial Review;
Determine the Impact of Strategies To
Vaccinate All Children for Influenza in
a Practice Setting, FOA IP09-007,
Initial Review
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92-463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Dates:
8 a.m.-5 p.m., May 21, 2009 (Closed).
8 a.m.-5 p.m., May 22, 2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of "Evaluation of New Technology
to Improve Delivery of Immunizations, FOA
IP09-005;" "Development, Implementation
and Evaluation of Strategies to Increase
Vaccination of Adolescents Affiliated with a
Medical Home, FOA IP09-006;" "Determine
the Impact of Strategies to Vaccinate all
Children for Influenza in a Practice Setting,
FOA IP09-007."
Contact Person for More Information:
Wendy Carr, PhD, CDC, 1600 Clifton Road,
NE., Mailstop E60, Atlanta, GA 30333,
Telephone: (404) 498-2276.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for ToxicDated: April 24, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9-10190 Filed 5-1-09; 8:45 am]
BILLING CODE 4163-18-P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NIDA.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute on Drug Abuse,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIDA.
Date: June 1, 2009.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Intramural Research Program,
National Institute on Drug Abuse, NIH, Johns
Hopkins Bayview Campus, Baltimore, MD
21224.
Contact Person: Stephen J. Heishman, PhD,
Research Psychologist, Clinical
Pharmacology Branch, Intramural Research
Program, National Institute on Drug Abuse,
National Institutes of Health, DHHS, 5500
Nathan Shock Drive, Baltimore, MD 21224.
(410) 550-1547.
(Catalogue of Federal Domestic Assistance
Program Nos. 93279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: April 27, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9-10099 Filed 5-1-09; 8:45 am]
BILLING CODE 4140-01-MSubstances and Disease Registry.
20487
Upcoming Pages
Here’s what’s next.
Search Inside
This issue can be searched. Note: Results may vary based on the legibility of text within the document.
Tools / Downloads
Get a copy of this page or view the extracted text.
Citing and Sharing
Basic information for referencing this web page. We also provide extended guidance on usage rights, references, copying or embedding.
Reference the current page of this Periodical.
United States. Office of the Federal Register. Federal Register, Volume 74, Number 84, May 4, 2009, Pages 20405-20558, periodical, May 4, 2009; Washington D.C.. (https://digital.library.unt.edu/ark:/67531/metadc132946/m1/90/: accessed April 23, 2024), University of North Texas Libraries, UNT Digital Library, https://digital.library.unt.edu; crediting UNT Libraries Government Documents Department.